Kezar Life Sciences, Inc. (KZR) NASDAQ
7.40
+0(+0.00%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
7.40
+0(+0.00%)
Currency In USD
| Market Cap | 46.02M |
| Enterprise Value | -23.53M |
| P/E Ratio | -0.97 |
| PEG Ratio | -0.1 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 0.77 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | 0.32 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -0.73 |
| Return On Equity | -0.64 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | -897,000 |
| EBITDA | -51.37M |
| Net Income | -56.03M |
| Diluted EPS | -7.66 |
| Total Cash | 71.88M |
| Total Cash/Share | 9.82 |
| Total Debt | 2.33M |
| Total Debt/Equity | 0.03 |
| Current Ratio | 11.52 |
| Book Value Per Share | 9.58 |
| 52-Week Change | 64.44 |
| 52-Week High | 7.55 |
| 52-Week Low | 3.53 |
| Moving Average 50 Days | 6.61 |
| Moving Average 200 Days | 5.43 |
| Average Volume | 57,167 |
| Shares Outstanding | 7.32M |
| % Held by Institutions | 60.91 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:10 |
| Last Split Date | October 30, 2024 |